Pharmacokinetics of nifedipine in Taiwanese

Shu-Chen Chien, Yow Shieng Uang, Hsiu Yi Lin, Kuang Yang Hsu

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

To elucidate the pharmacokinetics of nifedipine in Taiwanese, a retrospective review of nifedipine bioequivalence studies completed in Taiwan in the past 5 years was conducted. A total of 198 healthy male volunteers were given a single dose of a 10 mg Adalat® capsule as a reference drug after overnight fasting. Pharmacokinetic parameters derived from Adalat® administration were calculated by non-compartmental analysis with the WinNonlin program. After oral administration of an immediate-release dosage form of a 10 mg nifedipine capsule to Taiwan residents, a skewed distribution with no clear evidence of bimodality of pharmacokinetic parameters was observed. The mean Cmax was 143.12 ± 53.48 ng/ml, the mean AUC was 293.77 ± 115.62 ng·h/ml, the mean T 1/2 was 3.08 ± 1.61 h, and the median value of Tmax was 0.61 h. Compared with other published studies, the Cmax and AUC of nifedipine after 10 mg administration were significantly higher in Taiwanese than in British and American subjects. However, the C max and AUC were similar to those of Indian and Mexican subjects. According to the antimode of AUC distribution of 22.5 ng·h/ml/mg proposed by Kleinbloesem, 69.7% of Taiwanese can be categorized as slow metabolizers. Based on the results in this study, the majority of Taiwanese show lower activity of nifedipine metabolism.

Original languageEnglish
Pages (from-to)77-84
Number of pages8
JournalBiopharmaceutics and Drug Disposition
Volume25
Issue number2
DOIs
Publication statusPublished - Mar 2004

Fingerprint

Nifedipine
Pharmacokinetics
Area Under Curve
Taiwan
Capsules
Therapeutic Equivalency
Dosage Forms
Oral Administration
Fasting
Healthy Volunteers
Pharmaceutical Preparations

Keywords

  • Nifedipine
  • Pharmacokinetics
  • Taiwanese

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Pharmacokinetics of nifedipine in Taiwanese. / Chien, Shu-Chen; Uang, Yow Shieng; Lin, Hsiu Yi; Hsu, Kuang Yang.

In: Biopharmaceutics and Drug Disposition, Vol. 25, No. 2, 03.2004, p. 77-84.

Research output: Contribution to journalArticle

Chien, Shu-Chen ; Uang, Yow Shieng ; Lin, Hsiu Yi ; Hsu, Kuang Yang. / Pharmacokinetics of nifedipine in Taiwanese. In: Biopharmaceutics and Drug Disposition. 2004 ; Vol. 25, No. 2. pp. 77-84.
@article{b1f37c947c284adebd7eaabf0f38e820,
title = "Pharmacokinetics of nifedipine in Taiwanese",
abstract = "To elucidate the pharmacokinetics of nifedipine in Taiwanese, a retrospective review of nifedipine bioequivalence studies completed in Taiwan in the past 5 years was conducted. A total of 198 healthy male volunteers were given a single dose of a 10 mg Adalat{\circledR} capsule as a reference drug after overnight fasting. Pharmacokinetic parameters derived from Adalat{\circledR} administration were calculated by non-compartmental analysis with the WinNonlin program. After oral administration of an immediate-release dosage form of a 10 mg nifedipine capsule to Taiwan residents, a skewed distribution with no clear evidence of bimodality of pharmacokinetic parameters was observed. The mean Cmax was 143.12 ± 53.48 ng/ml, the mean AUC was 293.77 ± 115.62 ng·h/ml, the mean T 1/2 was 3.08 ± 1.61 h, and the median value of Tmax was 0.61 h. Compared with other published studies, the Cmax and AUC of nifedipine after 10 mg administration were significantly higher in Taiwanese than in British and American subjects. However, the C max and AUC were similar to those of Indian and Mexican subjects. According to the antimode of AUC distribution of 22.5 ng·h/ml/mg proposed by Kleinbloesem, 69.7{\%} of Taiwanese can be categorized as slow metabolizers. Based on the results in this study, the majority of Taiwanese show lower activity of nifedipine metabolism.",
keywords = "Nifedipine, Pharmacokinetics, Taiwanese",
author = "Shu-Chen Chien and Uang, {Yow Shieng} and Lin, {Hsiu Yi} and Hsu, {Kuang Yang}",
year = "2004",
month = "3",
doi = "10.1002/bdd.386",
language = "English",
volume = "25",
pages = "77--84",
journal = "Biopharmaceutics and Drug Disposition",
issn = "0142-2782",
publisher = "John Wiley and Sons Ltd",
number = "2",

}

TY - JOUR

T1 - Pharmacokinetics of nifedipine in Taiwanese

AU - Chien, Shu-Chen

AU - Uang, Yow Shieng

AU - Lin, Hsiu Yi

AU - Hsu, Kuang Yang

PY - 2004/3

Y1 - 2004/3

N2 - To elucidate the pharmacokinetics of nifedipine in Taiwanese, a retrospective review of nifedipine bioequivalence studies completed in Taiwan in the past 5 years was conducted. A total of 198 healthy male volunteers were given a single dose of a 10 mg Adalat® capsule as a reference drug after overnight fasting. Pharmacokinetic parameters derived from Adalat® administration were calculated by non-compartmental analysis with the WinNonlin program. After oral administration of an immediate-release dosage form of a 10 mg nifedipine capsule to Taiwan residents, a skewed distribution with no clear evidence of bimodality of pharmacokinetic parameters was observed. The mean Cmax was 143.12 ± 53.48 ng/ml, the mean AUC was 293.77 ± 115.62 ng·h/ml, the mean T 1/2 was 3.08 ± 1.61 h, and the median value of Tmax was 0.61 h. Compared with other published studies, the Cmax and AUC of nifedipine after 10 mg administration were significantly higher in Taiwanese than in British and American subjects. However, the C max and AUC were similar to those of Indian and Mexican subjects. According to the antimode of AUC distribution of 22.5 ng·h/ml/mg proposed by Kleinbloesem, 69.7% of Taiwanese can be categorized as slow metabolizers. Based on the results in this study, the majority of Taiwanese show lower activity of nifedipine metabolism.

AB - To elucidate the pharmacokinetics of nifedipine in Taiwanese, a retrospective review of nifedipine bioequivalence studies completed in Taiwan in the past 5 years was conducted. A total of 198 healthy male volunteers were given a single dose of a 10 mg Adalat® capsule as a reference drug after overnight fasting. Pharmacokinetic parameters derived from Adalat® administration were calculated by non-compartmental analysis with the WinNonlin program. After oral administration of an immediate-release dosage form of a 10 mg nifedipine capsule to Taiwan residents, a skewed distribution with no clear evidence of bimodality of pharmacokinetic parameters was observed. The mean Cmax was 143.12 ± 53.48 ng/ml, the mean AUC was 293.77 ± 115.62 ng·h/ml, the mean T 1/2 was 3.08 ± 1.61 h, and the median value of Tmax was 0.61 h. Compared with other published studies, the Cmax and AUC of nifedipine after 10 mg administration were significantly higher in Taiwanese than in British and American subjects. However, the C max and AUC were similar to those of Indian and Mexican subjects. According to the antimode of AUC distribution of 22.5 ng·h/ml/mg proposed by Kleinbloesem, 69.7% of Taiwanese can be categorized as slow metabolizers. Based on the results in this study, the majority of Taiwanese show lower activity of nifedipine metabolism.

KW - Nifedipine

KW - Pharmacokinetics

KW - Taiwanese

UR - http://www.scopus.com/inward/record.url?scp=1842525012&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1842525012&partnerID=8YFLogxK

U2 - 10.1002/bdd.386

DO - 10.1002/bdd.386

M3 - Article

C2 - 14872555

AN - SCOPUS:1842525012

VL - 25

SP - 77

EP - 84

JO - Biopharmaceutics and Drug Disposition

JF - Biopharmaceutics and Drug Disposition

SN - 0142-2782

IS - 2

ER -